Market Cap : 163.6 B | Enterprise Value : 194.4 B | PE Ratio : 27.25 | PB Ratio : 5.18 |
---|
NYSE:BMY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BMY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Bristol-Myers Squibb Co has the GF Score of 87, which implies that the company might have Good outperformance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
1. Financial Strength : 5/10Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Bristol-Myers Squibb Co might have Good outperformance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's GF Score distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's GF Score falls into.
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score | Performance Potential and All-in-One Screener Examples (1) |
91 - 100 | Highest outperformance potential |
81 - 90 | Good outperformance potential |
71 - 80 | Likely to have average performance |
51 - 70 | Poor future performance potential |
0 - 50 | Worst future performance potential, or not enough data |
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Vousden Karen H | director | 345 PARK AVENUE NEW YORK NY 10154 |
Samuels Theodore R. Ii | director | 1990 E. GRAND AVE. EL SEGUNDO CA 90245 |
Haller Julia A | director | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Paliwal Dinesh C | director | 5454 W 110TH STREET OVERLAND PARK KS 66211 |
Rice Derica W | director | LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
Emmens Matthew | director | C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139 |
Bertolini Robert J | director | C/O SCHERING PLOUGH CORP 2000 GALLOPING HILL RD KENILWORTH NJ 070333 |
Price Paula A | director | ONE CVS DRIVE WOONSOCKET RI 02895 |
Yale Phyllis R | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: YALE PHYLLIS R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Bonney Michael W | director | 65 HAYDEN AVE LEXINGTON MA 02421 |
Arduini Peter J | director | 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 |
Santiago Karen Murphy | officer: SVP & Controller | BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCE LINE ROAD PRINCETON NJ 08540 |
Caforio Giovanni | director, officer: Chairman and CEO | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCELINE ROAD LAWRENCEVILLE NJ 08543 |
Eid Joseph | officer: SVP,Head Glob. Medical Affairs | BRISTOL-MYERS SQUIBB COMPANY 3401 PRINCETON PIKE LAWRENCEVILLE NJ 08648 |
Leung Sandra | officer: EVP, General Counsel | C/O BRISTOL MYERS SQUIBB CO 345 PARK AVE NEW YORK NY 10164 |
Other Sources
By Zacks 2022-03-28
By Zacks 2022-03-30
By Zacks 2022-03-21
By Fool 2022-03-30
By tipranks.com 2022-03-21
By Zacks 2022-03-30
By Zacks 2022-03-21
By Zacks 2022-04-04
By Zacks 2022-04-05
By Zacks 2022-03-21
By Zacks 2022-03-29
By Zacks 2022-04-05
By Zacks 2022-03-16
By Zacks 2022-03-16